Cytomedix IncAdd to My Watchlist

CMXI:USOTC USIndustry: Medical-Biomedical/Gene
  • 0.37
  • 0.00  -0.13%
    Today's Change
  • 0.37
    Previous Close
  • Today
    52 Week Low - High
10:32 am ET 10/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding124 million
Market Cap$47 million
Return on Equity ttm-103.66%
Last DividendCMXI:US does not pay a dividend
EPS: Year Actual ttm-0.251
EPS: Year Est. ttm--
EPS: Quarterly Actual -0.09
EPS: Quarterly Est. --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate16.67
Company Description
Cytomedix, Inc. is a global biotechnology company focused on developing and commercializing cellular therapies that serve unmet clinical needs. The Company markets the Autogel process and Procuren, autologous wound healing therapies with multiple growth factors designed to initiate the body's natural healing process.
Revenue$12 million
Net Income$-20 million
Total Assets$46 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!